Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVATE prophylaxis regimens in severe or moderately severe hemophilia A
2005-000347-29Phase 4Completed
- Sponsor
- Baxter International Inc.
- Start
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of recombinant human coagulation factor VIII in hemophilia A (3 arms), sponsored by Baxter International Inc. Primary endpoint: Yearly transformed rate of bleeding episodes. Started Sep 2005; status: completed.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2005-000347-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000347-29.